一个多门小胞改善瘤积累和STING免疫疗法
Zachary T Bennett1,2, Animeshasavithri Krishnamurthy1,2, Shuyue Ye2,3
1Department of Biomedical Engineering, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, United States.
Journal of the American Chemical Society
|May 29, 2025
概括
工程混合细胞 (HySTING) 增强了STING免疫治疗的作用. 这些新型纳米粒子改善了全身循环和瘤积累,从而提高了癌症治疗效率.
科学领域:
- 免疫学
- 纳米技术
- 癌症学
背景情况:
- 干扰素基因刺激剂 (STING) 对先天免疫和抗癌反应至关重要.
- 目前的STING激活剂如PC7A细胞仅限于局部输送,并未优化为静脉注射.
- 改善STING激动剂的全身传递对于有效的癌症免疫疗法至关重要.
研究的目的:
- 设计一种新型杂交细胞 (HySTING),以改善系统传递和增强STING免疫疗法的有效性.
- 研究HySTING变种的pH敏感性和药理性质.
- 在体内评估HySTING的生物分布,瘤积累和抗癌作用.
主要方法:
- 使用PEG-b-PC7A和具有多值pKa值的二次聚合物设计的混合 (HySTING).
- 在相关细胞模型中评估了细胞稳定性,STING激活和膜不稳定.
- 在静脉注射后对小鼠的药物动力学概况,血液循环半衰期和瘤积累进行了评估.
- 选循环二核酸 (CDN) 来改善囊和稳定性.
- 在CT26小鼠结肠癌模型中测试了HySTING的疗效,包括用抗PD-1抗体进行组合治疗.
主要成果:
- HySTING变种表现出渐进的超pH敏感性,保持PC7A的药理性质.
- 与PC7A (<1小时) 相比,静脉注射HySTING显著改善了血液循环半衰期 (长达18小时).
- 在HySTING配方中,瘤积累量显著增加 (增加了多达17倍).
- 确定了HySTING IACS-8803配方,具有优异的瘤生长抑制和与αPD-1治疗的协同作用.
- 在CDN链接器中提替代增强了细胞封装和稳定性.
结论:
- 通过HySTING的多值pH敏感性,可以改善瘤的生物分布,并提高静脉注射STING免疫治疗的疗效.
- HySTING 是一种有前途的系统性施用STING激动剂平台,为癌症治疗提供了一种新的策略.
- 进一步开发HySTING配方有可能克服当前局部免疫疗法的局限性.
更多相关视频
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
3.1K
10:26Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
Published on: November 1, 2017
8.4K
相关概念视频
01:27Tumor Immunotherapy
489
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
489
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K